{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T15:47:56Z","timestamp":1769356076789,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Gates Foundation","doi-asserted-by":"publisher","award":["INV-010275"],"award-info":[{"award-number":["INV-010275"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006823","name":"Boston Children's Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009978","name":"The Oppenheimer Memorial Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009978","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.vaccine.2025.127016","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T16:54:02Z","timestamp":1741971242000},"page":"127016","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Association of serum anti-gbs2106 protein immunoglobulin G (IgG) in newborns and risk reduction of invasive group B streptococcus disease during early infancy."],"prefix":"10.1016","volume":"54","author":[{"given":"Vicky","family":"Gent","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nisha","family":"Dhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alane","family":"Izu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyaad","family":"Dangor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Briner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Hosken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaurav","family":"Kwatra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shabir A.","family":"Madhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.127016_bb0005","series-title":"StatPearls publishing copyright \u00a9 2024","author":"Hanna, M. and A. Noor, Streptococcus Group B, in StatPearls","year":"2024"},{"issue":"suppl_2","key":"10.1016\/j.vaccine.2025.127016_bb0010","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1093\/cid\/cix658","article-title":"Maternal colonization with group B Streptococcus and serotype distribution worldwide: systematic review and Meta-analyses","volume":"65","author":"Russell","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127016_bb0015","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/S1473-3099(16)30055-X","article-title":"Prevalence of maternal colonisation with group B streptococcus: a systematic review and meta-analysis","volume":"16","author":"Kwatra","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127016_bb0020","doi-asserted-by":"crossref","first-page":"9301","DOI":"10.1038\/s41598-020-66474-z","article-title":"Group B Streptococcus colonization rate and serotype distribution among pregnant women and their newborns at Adama hospital medical college, Ethiopia","volume":"10","author":"Ali","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127016_bb0025","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1136\/archdischild-2016-311419","article-title":"Challenges in reducing group B Streptococcus disease in African settings","volume":"102","author":"Nishihara","year":"2017","journal-title":"Arch Dis Child"},{"issue":"35 Pt A","key":"10.1016\/j.vaccine.2025.127016_bb0030","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1016\/j.vaccine.2017.02.025","article-title":"Prospects for preventing infant invasive GBS disease through maternal vaccination","volume":"35","author":"Madhi","year":"2017","journal-title":"Vaccine"},{"issue":"32","key":"10.1016\/j.vaccine.2025.127016_bb0035","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1016\/j.vaccine.2021.06.046","article-title":"Safety and immunogenicity of a prototype recombinant alpha-like protein subunit vaccine (GBS-NN) against group B Streptococcus in a randomised placebo-controlled double-blind phase 1 trial in healthy adult women","volume":"39","author":"Fischer","year":"2021","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127016_bb0040","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S1473-3099(16)00152-3","article-title":"Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b\/2 trial","volume":"16","author":"Madhi","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"14","key":"10.1016\/j.vaccine.2025.127016_bb0045","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJM197604012941404","article-title":"Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection","volume":"294","author":"Baker","year":"1976","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127016_bb0050","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1086\/323350","article-title":"Level of maternal antibody required to protect neonates against early-onset disease caused by group B Streptococcus type Ia: a multicenter, seroepidemiology study","volume":"184","author":"Lin","year":"2001","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127016_bb0055","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/infdis\/jit549","article-title":"Maternal antibody at delivery protects neonates from early onset group B streptococcal disease","volume":"209","author":"Baker","year":"2014","journal-title":"J Infect Dis"},{"issue":"48","key":"10.1016\/j.vaccine.2025.127016_bb0060","doi-asserted-by":"crossref","first-page":"6793","DOI":"10.1016\/j.vaccine.2015.10.019","article-title":"Correlates of protection of serotype-specific capsular antibody and invasive group B Streptococcus disease in south African infants","volume":"33","author":"Dangor","year":"2015","journal-title":"Vaccine"},{"issue":"47","key":"10.1016\/j.vaccine.2025.127016_bb0175","doi-asserted-by":"crossref","first-page":"6813","DOI":"10.1016\/j.vaccine.2021.10.022","article-title":"Infant serotype specific anti-capsular immunoglobulin G antibody and risk of invasive group B streptococcal disease","volume":"39","author":"Dangor","year":"2021","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127016_bb0070","doi-asserted-by":"crossref","first-page":"F403","DOI":"10.1136\/adc.2005.090472","article-title":"Association between low concentrations of antibodies to protein alpha and rib and invasive neonatal group B streptococcal infection","volume":"91","author":"Larsson","year":"2006","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127016_bb0065","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/cid\/ciw377","article-title":"The protective value of maternal group B Streptococcus antibodies: quantitative and functional analysis of naturally acquired responses to capsular polysaccharides and pilus proteins in European maternal sera","volume":"63","author":"Fabbrini","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127016_bb0075","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.vaccine.2023.01.071","article-title":"Association of infant rib and Alp1 surface protein N-terminal domain immunoglobulin G and invasive group B streptococcal disease in young infants","volume":"41","author":"Dangor","year":"2023","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127016_bb0080","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1586\/14760584.2015.1085307","article-title":"Association between maternal group B Streptococcus surface-protein antibody concentrations and invasive disease in their infants","volume":"14","author":"Dangor","year":"2015","journal-title":"Expert Rev Vaccines"},{"issue":"47\u201348","key":"10.1016\/j.vaccine.2025.127016_bb0085","doi-asserted-by":"crossref","first-page":"6905","DOI":"10.1016\/j.vaccine.2006.06.020","article-title":"Naturally occurring antibodies for the group B streptococcal surface immunogenic protein (sip) in pregnant women and newborn babies","volume":"24","author":"Manning","year":"2006","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127016_bb0090","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1128\/CVI.00030-08","article-title":"Recombinant group B Streptococcus alpha-like protein 3 is an effective immunogen and carrier protein","volume":"15","author":"Yang","year":"2008","journal-title":"Clin Vaccine Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127016_bb0095","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1086\/603540","article-title":"BibA induces opsonizing antibodies conferring in vivo protection against group B Streptococcus","volume":"200","author":"Santi","year":"2009","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127016_bb0100","doi-asserted-by":"crossref","first-page":"5216","DOI":"10.1128\/iai.65.12.5216-5221.1997","article-title":"Immunogenicity and protective efficacy of the alpha C protein of group B streptococci are inversely related to the number of repeats","volume":"65","author":"Gravekamp","year":"1997","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127016_bb0105","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1038\/s41598-018-20609-5","article-title":"Protective effect of group B Streptococcus type-III polysaccharide conjugates against maternal colonization, ascending infection and neonatal transmission in rodent models","volume":"8","author":"Chiarot","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2025.127016_bb0110","series-title":"Natural induced antibodies against group B streptococcus surface proteins and capsular polysaccharides","first-page":"139","author":"Dzanibe","year":"2017"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127016_bb0115","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","article-title":"A guide to vaccinology: from basic principles to new developments","volume":"21","author":"Pollard","year":"2021","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127016_bb0125","doi-asserted-by":"crossref","first-page":"16454","DOI":"10.1038\/s41598-017-16757-9","article-title":"Association between antibodies against group B Streptococcus surface proteins and recto-vaginal colonisation during pregnancy","volume":"7","author":"Dzanibe","year":"2017","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127016_bb0130","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0022-2836(05)80360-2","article-title":"Basic local alignment search tool","volume":"215","author":"Altschul","year":"1990","journal-title":"J Mol Biol"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127016_bb0135","doi-asserted-by":"crossref","first-page":"e1170","DOI":"10.1093\/cid\/ciaa1873","article-title":"Association of Group B Streptococcus (GBS) serum serotype-specific Anticapsular immunoglobulin G concentration and risk reduction for invasive GBS disease in south African infants: an observational birth-cohort","volume":"73","author":"Madhi","year":"2021","journal-title":"Matched Case-Control Study Clin Infect Dis"},{"issue":"44","key":"10.1016\/j.vaccine.2025.127016_bb0140","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.1016\/j.vaccine.2016.09.015","article-title":"Natural acquired group B Streptococcus capsular polysaccharide and surface protein antibodies in HIV-infected and HIV-uninfected children","volume":"34","author":"Dzanibe","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127016_bb0145","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3389\/fped.2018.00027","article-title":"Group B streptococcal maternal colonization and neonatal disease: molecular mechanisms and preventative approaches","volume":"6","author":"Patras","year":"2018","journal-title":"Front Pediatr"},{"issue":"22","key":"10.1016\/j.vaccine.2025.127016_bb0150","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1016\/j.vaccine.2017.04.013","article-title":"Association between functional antibody against group B Streptococcus and maternal and infant colonization in a Gambian cohort","volume":"35","author":"Le Doare","year":"2017","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127016_bb0120","first-page":"415","article-title":"Reduced Transplacental transfer of group B Streptococcus surface protein antibodies in HIV-infected mother-newborn dyads","volume":"215","author":"Dzanibe","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127016_bb0155","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.3389\/fimmu.2020.01920","article-title":"Update on Transplacental transfer of IgG subclasses: impact of maternal and fetal factors","volume":"11","author":"Clements","year":"2020","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127016_bb0160","article-title":"Benefits and risks of IgG Transplacental transfer","volume":"10","author":"Ciobanu","year":"2020","journal-title":"Diagnostics (Basel)"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127016_bb0165","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/infdis\/jiv064","article-title":"HIV-1 is associated with lower group B Streptococcus capsular and surface-protein IgG antibody levels and reduced Transplacental antibody transfer in pregnant women","volume":"212","author":"Dangor","year":"2015","journal-title":"J Infect Dis"},{"issue":"44","key":"10.1016\/j.vaccine.2025.127016_bb0170","doi-asserted-by":"crossref","first-page":"6930","DOI":"10.1016\/j.vaccine.2020.08.056","article-title":"Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in pregnant women and their infants: results from a randomized placebo-controlled phase II trial","volume":"38","author":"Swamy","year":"2020","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25003135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25003135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T14:21:41Z","timestamp":1750342901000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25003135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":35,"alternative-id":["S0264410X25003135"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127016","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of serum anti-gbs2106 protein immunoglobulin G (IgG) in newborns and risk reduction of invasive group B streptococcus disease during early infancy.","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"127016"}}